Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and treatment regimens for these patients.
Blood Cancer Awareness
Spread awareness by sharing and learning more. Post the social media graphic, sign up for a conference, March for Marrow, and MDS Webinars! Learn more about MDS.
Myelodysplastic Syndromes (MDS) Donate to Support Our Mission
